Our observations that CD133+ is a phenotypic marker of cancer stem cells in carcinoma cervix are supported by a recent study by Tyagi et al. who have further shown the role of the HPV E6 oncogene in maintenance of the stemness characteristics of cancer stem cells in carcinoma cervix [22]. The gene discussed is PROM1; the disease is cancer.